Parisa Mashayekhi

ORCID: 0000-0002-6373-3266 · 3 papers in corpus · active 2019-2022

Study types

  • article 3

Condition tags

  • endometriosis 3
article 2022
Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v20i10.12270

BACKGROUND: According to stem cell theory, it seems that the proliferation/differentiation imbalance in endometrial mesenchymal stem cells (enMSCs) is the leading cause of endometriosis, so targeting them to modulate stemness-relevant facto…

article 2020
Deregulation of Stemness-Related Genes in Endometriotic Mesenchymal Stem Cells: Further Evidence for Self-Renewal/Differentiation Imbalance
Iranian biomedical journal ·doi:10.29252/ibj.24.5.328

Background: Any irregularities in self-renewal/differentiation balance in endometriotic mesenchymal stem cells (MSCs) can change their fate and function, resulting in endometriosis development. This study aimed to evaluate the expression of…

article 2019
Endometriotic Mesenchymal Stem Cells Epigenetic Pathogenesis: Deregulation of miR-200b, miR-145, and let7b in A Functional Imbalanced Epigenetic Disease.
Cell journal ·doi:10.22074/cellj.2019.5903

OBJECTIVE: in endometriotic compared to non-endometriotic MSCs. These microRNAs are involved in biological pathways related to proliferation and differentiation of stem cells. Their aberrant expressions can disturb the proliferation/ differ…